Literature DB >> 21925440

Reporting of clinical trials: publication, authorship, and trial registration.

Raphael E Bonita1, Suzanne Adams, David J Whellan.   

Abstract

Transparency is the foundation on which all of research integrity rests. The public trust from patients, providers, and policy makers depends on fidelity to the mandates of accountability and access. Two important foundational practices for maintaining transparency in research and the reporting of clinical trials discussed in this review concern manuscript authorship and clinical trial registry, recognizing recent controversies regarding honorary and ghost authorship in the publication of industry-sponsored studies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21925440     DOI: 10.1016/j.hfc.2011.06.009

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  3 in total

1.  [Not Available].

Authors:  Eve Courbon; Cynthia Tanguay; Denis Lebel; Jean-François Bussières
Journal:  Can J Hosp Pharm       Date:  2014-05

Review 2.  Systematic review on the primary and secondary reporting of the prevalence of ghostwriting in the medical literature.

Authors:  Serina Stretton
Journal:  BMJ Open       Date:  2014-07-14       Impact factor: 2.692

Review 3.  Barriers to and facilitators of interventions to counter publication bias: thematic analysis of scholarly articles and stakeholder interviews.

Authors:  Christina Kien; Barbara Nußbaumer; Kylie J Thaler; Ursula Griebler; Megan G Van Noord; Petra Wagner; Gerald Gartlehner
Journal:  BMC Health Serv Res       Date:  2014-11-13       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.